Literature DB >> 2206139

Kinetics and mechanism of uptake of platinum-based pharmaceuticals by the rat small intestine.

S P Binks1, M Dobrota.   

Abstract

The absorption of two platinum-based pharmaceuticals, cisplatin and carboplatin, was studied using in vitro and in situ models. By utilizing everted rat small intestine, it was found that absorption of both drugs was linear with time up to 60 min and was not saturable up to a concentration of 1.0 mM. Moreover, uptake against a concentration gradient could not be demonstrated and absorption was not reduced by metabolic inhibition or anoxic conditions. These results indicate the lack of involvement of an active transport mechanism for cisplatin and carboplatin and imply that absorption across the gastrointestinal tract is by passive diffusion. Cisplatin was absorbed more readily than carboplatin, both in vitro and in situ. In situ both drugs were found to disappear from the intestinal lumen following first-order kinetics. The results of in situ studies indicate that a decrease in pH of the perfusion medium leads to an increase in absorption of carboplatin into the systemic blood. This report establishes the fact that both cisplatin and carboplatin are absorbed across the gastro-intestinal tract and indicates that preclinical trials involving oral administration of platinum-based pharmaceuticals could be justified.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2206139     DOI: 10.1016/0006-2952(90)90400-f

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  25 in total

1.  Cell cycle checkpoint models for cellular pharmacology of paclitaxel and platinum drugs.

Authors:  Ardith W El-Kareh; Rachel E Labes; Timothy W Secomb
Journal:  AAPS J       Date:  2008-02-05       Impact factor: 4.009

2.  Cisplatin impairs fluid and electrolyte absorption in rat small intestine: a role for 5-hydroxytryptamine.

Authors:  C P Bearcroft; P Domizio; F H Mourad; E A André; M J Farthing
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

3.  Electrochemical Measurement of Dopamine Release and Uptake in Zebrafish Following Treatment with Carboplatin.

Authors:  Thomas M Field; Mimi Shin; Chase S Stucky; Joseph Loomis; Michael A Johnson
Journal:  Chemphyschem       Date:  2018-04-25       Impact factor: 3.102

Review 4.  Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking.

Authors:  Xue Xue; Matthew D Hall; Qiang Zhang; Paul C Wang; Michael M Gottesman; Xing-Jie Liang
Journal:  ACS Nano       Date:  2013-12-10       Impact factor: 15.881

5.  Modeling iontophoretic drug delivery in a microfluidic device.

Authors:  Maryam Moarefian; Rafael V Davalos; Danesh K Tafti; Luke E Achenie; Caroline N Jones
Journal:  Lab Chip       Date:  2020-09-01       Impact factor: 6.799

Review 6.  The path for metal complexes to a DNA target.

Authors:  Alexis C Komor; Jacqueline K Barton
Journal:  Chem Commun (Camb)       Date:  2013-05-07       Impact factor: 6.222

7.  Cisplatin interaction with phosphatidylserine bilayer studied by solid-state NMR spectroscopy.

Authors:  Magnus Jensen; Morten Bjerring; Niels Chr Nielsen; Willy Nerdal
Journal:  J Biol Inorg Chem       Date:  2009-09-19       Impact factor: 3.358

Review 8.  Clinical pharmacokinetics of carboplatin.

Authors:  W J van der Vijgh
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

9.  Impaired hydrolysis of cisplatin derivatives to aquated species prevents energy-dependent uptake in GLC4 cells resistant to cisplatin.

Authors:  Elene Pereira-Maia; Arlette Garnier-Suillerot
Journal:  J Biol Inorg Chem       Date:  2003-05-17       Impact factor: 3.358

Review 10.  Polymorphic transporters and platinum pharmacodynamics.

Authors:  Jason A Sprowl; Rachel A Ness; Alex Sparreboom
Journal:  Drug Metab Pharmacokinet       Date:  2012-09-18       Impact factor: 3.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.